Labcorp (LH): are the analysts right?

Labcorp · Health Care · ref. ETF XLV · 50 calls · price $283.86
What the company does: Labcorp Holdings Inc. fournit des services de laboratoire et diagnostique.
📈 1-year price
$283.86+10.3% over range
Jul 8, 25low $243.04 · high $290.93Jul 7, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
75% recommend buying · 4 analysts

🎯 Analyst price target on LH

High target · 2 analysts$330+16.3%
Median target · 4 analysts$313+10.3%
Low target · 2 analysts$300+5.7%
Current price$283.86

🗳️ The analyst consensus

Analyst breakdown · 4 (6 months)
Strong Buy0%
Buy75%
Hold25%
Sell0%
Strong Sell0%

💰 Labcorp dividend

1.01%annual yield
That's ~$2.88 per share per year.

✅ Historical analyst reliability on LH

Most reliable analysts on LH (% profitable · 365j · ≥2 calls)
Baird 100% +20.8% 5
B of A Securities 100% +15.1% 2
UBS 100% +12.5% 2
Jefferies 100% +11.5% 2
Truist Securities 100% +10.9% 3
Morgan Stanley 100% +6.5% 2

📊 What $1,000 invested in Labcorp would be worth

In short — $1,000 invested in Labcorp 10 years ago would be worth $2,636 today, i.e. +10%/yr on average. Best year: 2021 (+54%), worst: 2022 (-25%). Price performance, excluding dividends.

If I'd invested $1,000 in Labcorp

InvestmentWorth todayGain
1 years ago$1,221+22%
3 years ago$1,384+38%
5 years ago$1,601+60%
10 years ago$2,636+164%
since inception (1990)$11,718+1072%

Return by year (Labcorp)

YearReturn$1,000 invested at year start
2026 (YTD)+12%$1,116 (+12%)
2025+9%$1,221 (+22%)
2024+1%$1,232 (+23%)
2023+12%$1,384 (+38%)
2022-25%$1,037 (+4%)
2021+54%$1,601 (+60%)
2020+20%$1,927 (+93%)
2019+34%$2,579 (+158%)
2018-21%$2,043 (+104%)
2017+24%$2,539 (+154%)
2016+4%$2,636 (+164%)
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

🔎 Detailed analyses

👥 Analysts & forecasts📊 Returns & performance💰 Dividend
📈 Fundamentals, technical momentum and live news will show here on the final site (loaded live from the same origin as the API).

📋 All analyst calls on LH

▲ Outperform · 🎯$300
Price at call : $273.26 — upside +10%
Today : $283.86 — upside +6%
🎯 on LH : 100% (1 call matured) · 📊 on Health : 47.6% · +1.3% (147 calls)
in progress (365j)
matures : Apr 8, 27
Piper Sandler
Feb 24, 26
■ Neutral neutral · not a buy · 🎯$300
Price at call : $282.78 — gap to target +6%
Today : $283.86 — gap to target +6%
🎯 on LH : no call matured yet · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : Feb 24, 27
JP Morgan
Feb 18, 26
▲ Overweight · 🎯$330
Price at call : $282.48 — upside +17%
Today : $283.86 — upside +16%
🎯 on LH : no call matured yet · 📊 on Health : 53.6% · +5.2% (349 calls)
in progress (365j)
matures : Feb 18, 27
Baird
Feb 18, 26
▲ Outperform · 🎯$326
Price at call : $278.76 — upside +17%
Today : $283.86 — upside +15%
🎯 on LH : 100% (5 calls matureds) · 📊 on Health : 52.3% · +7.1% (287 calls)
in progress (365j)
matures : Feb 18, 27
JP Morgan
Feb 6, 26
▲ Overweight · 🎯$319
Price at call : $274.01 — upside +16%
Today : $283.86 — upside +12%
🎯 on LH : no call matured yet · 📊 on Health : 53.6% · +5.2% (349 calls)
in progress (365j)
matures : Feb 6, 27
JP Morgan
Nov 7, 25
▲ Overweight · 🎯$317
Price at call : $261.13 — upside +21%
Today : $283.86 — upside +12%
🎯 on LH : no call matured yet · 📊 on Health : 53.6% · +5.2% (349 calls)
in progress (365j)
matures : Nov 7, 26
UBS
Oct 29, 25
▲ Buy · 🎯$320
Price at call : $252.33 — upside +27%
Today : $283.86 — upside +13%
🎯 on LH : 100% (2 calls matureds) · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : Oct 29, 26
UBS
Oct 17, 25
▲ Buy · 🎯$325
Price at call : $290.93 — upside +12%
Today : $283.86 — upside +14%
🎯 on LH : 100% (2 calls matureds) · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : Oct 17, 26
Mizuho
Oct 17, 25
▲ Outperform · 🎯$320
Price at call : $285.94 — upside +12%
Today : $283.86 — upside +13%
🎯 on LH : no call matured yet · 📊 on Health : 53.8% · +4.4% (208 calls)
in progress (365j)
matures : Oct 17, 26
▲ Outperform · 🎯$305
Price at call : $275.05 — upside +11%
Today : $283.86 — upside +7%
🎯 on LH : 100% (1 call matured) · 📊 on Health : 47.6% · +1.3% (147 calls)
in progress (365j)
matures : Oct 3, 26
Barclays
Oct 2, 25
■ Equal-Weight neutral · not a buy · 🎯$290
Price at call : $276.94 — gap to target +5%
Today : $283.86 — gap to target +2%
🎯 on LH : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Oct 2, 26
▲ Buy · 🎯$310
Price at call : $261.88 — upside +18%
Today : $283.86 — upside +9%
🎯 on LH : 100% (3 calls matureds) · 📊 on Health : 50% · +2.1% (248 calls)
in progress (365j)
matures : Jul 25, 26
UBS
Jul 25, 25
▲ Buy · 🎯$305
Price at call : $261.88 — upside +16%
Today : $283.86 — upside +7%
🎯 on LH : 100% (2 calls matureds) · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : Jul 25, 26
▲ Outperform · 🎯$300
Price at call : $261.88 — upside +15%
Today : $283.86 — upside +6%
🎯 on LH : 100% (1 call matured) · 📊 on Health : 47.6% · +1.3% (147 calls)
in progress (365j)
matures : Jul 25, 26
▲ Overweight · 🎯$306
Price at call : $264.96 — upside +15%
Today : $283.86 — upside +8%
🎯 on LH : 100% (2 calls matureds) · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Jul 25, 26
Baird
Jul 25, 25
▲ Outperform · 🎯$302
Price at call : $264.96 — upside +14%
Today : $283.86 — upside +6%
🎯 on LH : 100% (5 calls matureds) · 📊 on Health : 52.3% · +7.1% (287 calls)
in progress (365j)
matures : Jul 25, 26
UBS
Jul 18, 25
▲ Buy · 🎯$282
Price at call : $243.04 — upside +16%
Today : $283.86 — upside -1%
🎯 on LH : 100% (2 calls matureds) · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : Jul 18, 26
▲ Outperform · 🎯$285
Price at call : $259.07 — upside +10%
Today : $283.86 — upside +0%
🎯 on LH : 100% (1 call matured) · 📊 on Health : 47.6% · +1.3% (147 calls)
in progress (365j)
matures : Jul 9, 26
Barclays
Jun 25, 25
■ Equal-Weight neutral · not a buy · 🎯$275
Price at call : $256.98 — gap to target +7%
Today : $283.86 — gap to target -3%
🎯 on LH : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Jun 25, 26
▲ Overweight · 🎯$283
Price at call : $261.65 — upside +8%
Today : $283.86 — upside -0%
Expected +8% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on LH : 100% (2 calls matureds) · 📊 on Health : 51.7% · +5.3% (804 calls)
+1.7%
stock +2% · XLV +12%
▲ Buy · 🎯$290
Price at call : $250.01 — upside +16%
Today : $283.86 — upside +2%
Expected +16% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on LH : 100% (3 calls matureds) · 📊 on Health : 50% · +2.1% (248 calls)
+1.8%
stock +2% · XLV +11%
■ Neutral neutral · not a buy · 🎯$280
Price at call : $245.9 — gap to target +14%
Today : $283.86 — gap to target -1%
🎯 on LH : no call matured yet · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : May 6, 26
Barclays
May 1, 25
■ Equal-Weight neutral · not a buy · 🎯$250
Price at call : $241.28 — gap to target +4%
Today : $283.86 — gap to target -12%
🎯 on LH : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : May 1, 26
Baird
Apr 30, 25
▲ Outperform · 🎯$267
Price at call : $241.28 — upside +11%
Today : $283.86 — upside -6%
Expected +11% · Actual +6% · Reason (≥ +15%) : ✗ No
🎯 on LH : 100% (5 calls matureds) · 📊 on Health : 52.3% · +7.1% (287 calls)
+6.0%
stock +6% · XLV +6%
▲ Buy · 🎯$274
Price at call : $221.46 — upside +24%
Today : $283.86 — upside -3%
Expected +24% · Actual +19% · Reason (≥ +15%) : ✓ Yes
🎯 on LH : 100% (3 calls matureds) · 📊 on Health : 50% · +2.1% (248 calls)
+19.3%
stock +19% · XLV +8%
Barclays
Apr 10, 25
■ Equal-Weight neutral · not a buy · 🎯$240
Price at call : $221.46 — gap to target +8%
Today : $283.86 — gap to target -15%
🎯 on LH : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Apr 10, 26
▲ Buy · 🎯$276
Price at call : $236.37 — upside +17%
Today : $283.86 — upside -3%
Expected +17% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on LH : 100% (1 call matured) · 📊 unranked overall
+15.8%
stock +16% · XLV +2%
Citigroup
Mar 4, 25
▲ Buy · 🎯$300
Price at call : $256.81 — upside +17%
Today : $283.86 — upside +6%
Expected +17% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on LH : 100% (1 call matured) · 📊 on Health : 53.4% · +2.8% (496 calls)
+9.4%
stock +9% · XLV +6%
Piper Sandler
Feb 10, 25
■ Neutral neutral · not a buy · 🎯$260
Price at call : $245.14 — gap to target +6%
Today : $283.86 — gap to target -8%
🎯 on LH : no call matured yet · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : Feb 10, 26
Barclays
Feb 7, 25
■ Equal-Weight neutral · not a buy · 🎯$260
Price at call : $245.08 — gap to target +6%
Today : $283.86 — gap to target -8%
🎯 on LH : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Feb 7, 26
Jefferies
Feb 7, 25
▲ Buy · 🎯$290
Price at call : $246.27 — upside +18%
Today : $283.86 — upside +2%
Expected +18% · Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on LH : 100% (2 calls matureds) · 📊 on Health : 50.5% · +4.5% (376 calls)
+11.3%
stock +11% · XLV +7%
Barclays
Feb 3, 25
■ Equal-Weight neutral · not a buy · 🎯$271
Price at call : $246.67 — gap to target +10%
Today : $283.86 — gap to target -5%
🎯 on LH : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Feb 3, 26
UBS
Jan 28, 25
▲ Buy · 🎯$286
Price at call : $246.22 — upside +16%
Today : $283.86 — upside +1%
Expected +16% · Actual +10% · Reason (≥ +15%) : ✗ No
🎯 on LH : 100% (2 calls matureds) · 📊 on Health : 52.1% · +3.4% (340 calls)
+9.6%
stock +10% · XLV +6%
▲ Outperform · 🎯$265
Price at call : $234.31 — upside +13%
Today : $283.86 — upside -7%
Expected +13% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on LH : 100% (1 call matured) · 📊 on Health : 47.6% · +1.3% (147 calls)
+8.7%
stock +9% · XLV +13%
▲ Overweight · 🎯$270
Price at call : $226.31 — upside +19%
Today : $283.86 — upside -5%
Expected +19% · Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on LH : 100% (2 calls matureds) · 📊 on Health : 51.7% · +5.3% (804 calls)
+11.4%
stock +11% · XLV +12%
▲ Buy · 🎯$271
Price at call : $229.62 — upside +18%
Today : $283.86 — upside -5%
Expected +18% · Actual +15% · Reason (≥ +15%) : ✗ No
🎯 on LH : 100% (2 calls matureds) · 📊 on Health : 48.6% · +2.3% (352 calls)
+14.7%
stock +15% · XLV +12%
Jefferies
Dec 10, 24
▲ Buy · 🎯$275
Price at call : $234.54 — upside +17%
Today : $283.86 — upside -3%
Expected +17% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on LH : 100% (2 calls matureds) · 📊 on Health : 50.5% · +4.5% (376 calls)
+11.7%
stock +12% · XLV +6%
HSBC
Oct 30, 24
▲ Buy
Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on LH : 100% (1 call matured) · 📊 on Health : 53.6% · +1.4% (28 calls)
+11.3%
stock +11% · XLV -2%
Piper Sandler
Oct 28, 24
■ Neutral neutral · not a buy · 🎯$240
Price at call : $228.09 — gap to target +5%
Today : $283.86 — gap to target -15%
🎯 on LH : no call matured yet · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : Oct 28, 25
Barclays
Oct 25, 24
■ Equal-Weight neutral · not a buy · 🎯$249
Price at call : $227.38 — gap to target +10%
Today : $283.86 — gap to target -12%
🎯 on LH : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Oct 25, 25
Baird
Oct 25, 24
▲ Outperform · 🎯$289
Price at call : $228.63 — upside +26%
Today : $283.86 — upside +2%
Expected +26% · Actual +21% · Reason (≥ +15%) : ✓ Yes
🎯 on LH : 100% (5 calls matureds) · 📊 on Health : 52.3% · +7.1% (287 calls)
+20.6%
stock +21% · XLV -1%
▲ Buy · 🎯$260
Price at call : $225.87 — upside +15%
Today : $283.86 — upside -8%
Expected +15% · Actual +15% · Reason (≥ +15%) : ✓ Yes
🎯 on LH : 100% (2 calls matureds) · 📊 on Health : 48.6% · +2.3% (352 calls)
+15.5%
stock +15% · XLV -12%
■ Hold neutral · not a buy · 🎯$230
Price at call : $228.57 — gap to target +1%
Today : $283.86 — gap to target -19%
🎯 on LH : no call matured yet · 📊 on Health : 53.3% · +4.4% (289 calls)
in progress (365j)
matures : Aug 2, 25
UBS
Aug 2, 24
▲ Buy · 🎯$270
Price at call : $228.57 — upside +18%
Today : $283.86 — upside -5%
Expected +18% · Actual +15% · Reason (≥ +15%) : ✓ Yes
🎯 on LH : 100% (2 calls matureds) · 📊 on Health : 52.1% · +3.4% (340 calls)
+15.4%
stock +15% · XLV -9%
Barclays
Aug 2, 24
■ Equal-Weight neutral · not a buy · 🎯$249
Price at call : $228.57 — gap to target +9%
Today : $283.86 — gap to target -12%
🎯 on LH : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Aug 2, 25
Baird
Aug 2, 24
▲ Outperform · 🎯$277
Price at call : $228.57 — upside +21%
Today : $283.86 — upside -2%
Expected +21% · Actual +15% · Reason (≥ +15%) : ✓ Yes
🎯 on LH : 100% (5 calls matureds) · 📊 on Health : 52.3% · +7.1% (287 calls)
+15.4%
stock +15% · XLV -9%
▲ Buy · 🎯$275
Price at call : $236 — upside +17%
Today : $283.86 — upside -3%
Expected +17% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on LH : 100% (3 calls matureds) · 📊 on Health : 50% · +2.1% (248 calls)
+11.8%
stock +12% · XLV -12%
■ In-Line neutral · not a buy · 🎯$215
Price at call : $200.37 — gap to target +7%
Today : $283.86 — gap to target -24%
🎯 on LH : 100% (1 call matured) · 📊 on Health : 47.6% · +1.3% (147 calls)
in progress (365j)
matures : Jul 9, 25
Baird
Jul 8, 24
▲ Outperform · 🎯$261
Price at call : $199.35 — upside +31%
Today : $283.86 — upside -8%
Expected +31% · Actual +30% · Reason (≥ +15%) : ✓ Yes
🎯 on LH : 100% (5 calls matureds) · 📊 on Health : 52.3% · +7.1% (287 calls)
+30.0%
stock +30% · XLV -7%
Baird
Jun 13, 24
▲ Outperform · 🎯$258
Price at call : $199.88 — upside +29%
Today : $283.86 — upside -9%
Expected +29% · Actual +32% · Reason (≥ +15%) : ✓ Yes
🎯 on LH : 100% (5 calls matureds) · 📊 on Health : 52.3% · +7.1% (287 calls)
+32.1%
stock +32% · XLV -7%
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)